We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCI icon
651
Rogers Communications
RCI
$18.8B
$658K 0.01%
16,431
+3,368
+26% +$140K
QRVO icon
652
Qorvo
QRVO
$8.09B
$654K 0.01%
5,914
-37,951
-87% -$3.76M
TAP icon
653
Molson Coors Class B
TAP
$7.97B
$652K 0.01%
18,989
-31,586
-62% -$1.26M
DINO icon
654
HF Sinclair
DINO
$16.1B
$646K 0.01%
22,139
-55,638
-72% -$1.65M
BURL icon
655
Burlington
BURL
$23.3B
$641K 0.01%
3,256
-1,160
-26% -$218K
HEI.A icon
656
HEICO Corp Class A
HEI.A
$36.8B
$635K 0.01%
7,822
-3,391
-30% -$263K
NNN icon
657
NNN REIT
NNN
$9.37B
$629K 0.01%
17,736
-3,482
-16% -$114K
EXR icon
658
Extra Space Storage
EXR
$32.2B
$627K 0.01%
6,788
-5,107
-43% -$475K
LW icon
659
Lamb Weston
LW
$7.51B
$623K 0.01%
9,746
-2,242
-19% -$135K
GDDY icon
660
GoDaddy
GDDY
$13.6B
$622K 0.01%
8,479
-2,982
-26% -$214K
HSIC icon
661
Henry Schein
HSIC
$9.76B
$612K 0.01%
10,474
-3,941
-27% -$220K
CBOE icon
662
Cboe Global Markets
CBOE
$31.1B
$611K 0.01%
6,548
-3,286
-33% -$324K
NTR icon
663
Nutrien
NTR
$33.3B
$604K 0.01%
18,869
+4,717
+33% +$164K
AVLR
664
DELISTED
Avalara, Inc.
AVLR
$600K 0.01%
+4,510
New +$443K
ROKU icon
665
Roku
ROKU
$21.3B
$593K 0.01%
5,086
-1,200
-19% -$137K
CGNX icon
666
Cognex
CGNX
$10B
$590K 0.01%
9,872
-61,713
-86% -$3.35M
EVA
667
DELISTED
Enviva Inc.
EVA
$590K 0.01%
+16,367
New +$544K
ELAN icon
668
Elanco Animal Health
ELAN
$12.7B
$577K 0.01%
26,909
-5,581
-17% -$123K
RNAM
669
DELISTED
Avidity Biosciences
RNAM
$565K 0.01%
+20,000
New +$577K
LSXMK
670
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$560K 0.01%
20,990
-8,504
-29% -$219K
RDHL
671
Redhill Biopharma
RDHL
$4.44M
$553K 0.01%
83
+12
+17% +$82.6K
WU icon
672
Western Union
WU
$2.58B
$531K 0.01%
24,563
-107,971
-81% -$2.19M
MXIM
673
DELISTED
Maxim Integrated Products
MXIM
$530K 0.01%
+8,747
New +$487K
HWM icon
674
Howmet Aerospace
HWM
$114B
$527K 0.01%
33,235
-11,953
-26% -$157K
ULTA icon
675
Ulta Beauty
ULTA
$21.6B
$523K 0.01%
2,569
-1,246
-33% -$268K

Similar funds

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.